Home › Researcher directory › Jordan Mark Schecter

Jordan Mark Schecter

Affiliation : Janssen Research & Development (United States)

• 1Publications (affiliation in the United States)
• 229Total publications
• 11392Citations
• 37h-index

ORCIDOpenAlex

Research profile

Jordan Mark Schecter has 1 indexed publication (2023). Their work appears in “Clinical Lymphoma Myeloma & Leukemia”. Their work is co-authored with at least 12 researchers, including institutions in Spain, Kuwait, Morocco.

Is this you? Get your research seen

Create your free DzCademia profile and add your articles: they will show up more easily on Google and in AI assistants like ChatGPT, so more people can read and cite your work.

Create my free profile Add my publications

Research areas

• Multiple Myeloma Research and Treatments
• CAR-T cell therapy research
• Chronic Lymphocytic Leukemia Research
• Protein Degradation and Inhibitors
• Monoclonal and Polyclonal Antibodies Research

Publications (1)

• POSTER: MM-304 Efficacy Outcomes and Characteristics of Patients With Multiple Myeloma (MM) Who Achieved Sustained Minimal Residual Disease Negativity After Treatment With Ciltacabtagene Autoleucel (cilta-cel) in CARTITUDE-1
  2023 · Clinical Lymphoma Myeloma & Leukemia

Collaborations

Partner institutions : Legend Biotech (United States) · Memorial Sloan Kettering Cancer Center · Emory University · Genentech · Vanderbilt University

Co-authors’ countries : Spain · Kuwait · Morocco

Co-authors

• Dong Geng
• J. Blake Bartlett
• Tzu‐Min Yeh
• Muhammad Akram
• Thomas G. Martin
• Lida Bubuteishvili Pacaud
• Bruno Pavia
• Nikhil C. Munshi
• Adam D. Cohen
• Jesús F. San Miguel
• Yi Lin
• Enrique Zudaire

Bibliographic data from OpenAlex (open database).